ProMIS Neurosciences Inc PMN

2020 outlook review

[Thenorth1990]

excerpt from 2020 outlook / 2019 annual result , this timeline is not valid anymore right ?


"As a prelude to the first PMN310 clinical trial in AD, ProMIS anticipates using a novel biomarker approach that may show evidence of slowing of neuronal death early in the development program. To accomplish this, we initiated the pilot phase of a natural history evaluation of biomarker changes in untreated, mild AD patients in February 2020.We anticipate potential initial results of the first clinical trial with PMN310 in late 2021."

[Gbathat]

correct.  They used the term anticipate without the caveat that this was dependent on funding that was clearly not locked in at this point.  This is why many of us have been losing patience, except for a few longs who are apparently close to the company and have more trust.   I think ProMIS will do well going forward. I do think that the last few years were more uncertain than

[Thenorth1990]

similar thoughts hope all this wait is for good. Cheers